Cancer Registry in India: Detailed Explanation
India's cancer registration system operates through the National Cancer Registry Programme (NCRP), established in 1982 by the Indian Council of Medical Research, comprising 28 Population-Based Cancer Registries (PBCRs) and multiple Hospital-Based Cancer Registries (HBCRs) that collectively document cancer incidence, patterns, and outcomes across the country 1, 2.
Structure and Coverage
The NCRP functions through two complementary registry types:
- Population-Based Cancer Registries (PBCRs): Currently 28 active registries covering less than 15% of urban and only 1% of rural populations 3, 4
- Hospital-Based Cancer Registries (HBCRs): 58 registries collecting detailed clinical data from major cancer treatment centers 2
Critical Coverage Limitations
The most significant weakness is the severe geographic imbalance—registries predominantly cover urban areas while rural populations remain largely undocumented 4, 5. This creates substantial bias in understanding India's true cancer burden, particularly problematic given that approximately 65-70% of India's population resides in rural areas.
Data Collection Methods
PBCR Approach
PBCRs employ certified tumor registrars who collect data through multiple sources 2:
- Hospital medical records abstraction
- Pathology laboratory reports
- Death certificates
- Village and home visits to interview cancer patients in rural areas—a unique adaptation to India's healthcare access challenges 3
HBCR Innovations
Recent technological advancement includes the Onco-Insight platform with EMR integration, which reduced data abstraction time from 27.17 minutes to 15.07 minutes per case while improving data completeness 6. This system automatically retrieves structured variables from electronic medical records while allowing manual entry for unstructured data.
Data Captured
Standard Variables Collected
- Patient demographics (age, sex, geography)
- Cancer site and morphology
- Stage at diagnosis
- First course of treatment
- Survival outcomes 2
Socioeconomic Data Collection Gaps
Most PBCRs collect but rarely report data on education, marital status, mother tongue, and religion; only two registries collect income/occupation data, and none systematically collect caste information 3. This represents a critical missed opportunity for understanding cancer health inequities in India's socially stratified population.
Current Cancer Burden Estimates
For 2022, India's estimated cancer incidence is 1,461,427 new cases (crude rate: 100.4 per 100,000 population), with projections showing a 12.8% increase by 2025 compared to 2020 1. Leading cancer sites are:
- Males: Lung cancer predominates
- Females: Breast cancer leads
- Children (0-14 years): Lymphoid leukemia (29.2% boys, 24.2% girls) 1
Geographic Variation
Aizawl district shows the highest age-adjusted incidence rate among males (269.4), while Papumpare district leads for females (219.8) 2. The Gangetic belt region (northern and eastern states) demonstrates particularly high burden for specific cancers like gallbladder cancer, accounting for 84.6% of cases in one major registry 7.
Stage at Presentation
The majority of cancers are diagnosed at locally advanced stages 2:
- Breast cancer: 57.0% locally advanced
- Cervical cancer: 60.0% locally advanced
- Head and neck cancers: 66.6% locally advanced
- Stomach cancer: 50.8% locally advanced
- Lung cancer: 44.0% males and 47.6% females present with distant metastasis
This late-stage presentation pattern reflects systemic issues in early detection and screening access.
Major Challenges
Data Quality Issues
Accuracy concerns include incomplete diagnostic information, inconsistent morphological coding, and missing staging data in significant proportions of cases 8. The Italian experience with neuroendocrine tumors demonstrated that manual review with expert consultation can lead to reclassification of up to 1,300 cases initially coded incorrectly, highlighting similar potential issues in Indian registries 8.
Operational Barriers
- Funding constraints and staff retention difficulties 3
- Challenges with medical record data abstraction
- Address verification complications in mobile populations
- Cancer stigma affecting patient cooperation
- Patient migration between treatment centers 3
- Lack of standardized death registration systems 3
Timeliness
Data publication typically lags 4-5 years behind collection, limiting real-time cancer surveillance and rapid policy response 4, 5.
Opportunities for Improvement
Short-term Solutions
- Expansion of cancer atlas projects for better geographic representation 4
- Real-time data collection systems to reduce publication lag 4
- Integration of Aadhaar (UID) numbers during registration to enable patient tracking across facilities and reduce duplication 4
- Establishing linkages between PBCRs and HBCRs for comprehensive data capture 4
Long-term Strategic Initiatives
Development of new PBCRs linked with existing Health and Demographic Surveillance Systems (HDSS) would increase both coverage and sustainability 4. This approach leverages existing infrastructure while expanding rural reach.
Technology Integration
The EMR-integrated Onco-Insight platform demonstrates feasibility of automated data retrieval, though further standardization and AI-enabled extraction could strengthen efficiency 6. Expansion of structured data fields in EMRs would facilitate automated capture of treatment details, follow-up information, and recurrence data.
Critical Gaps Requiring Action
The absence of systematic socioeconomic data reporting prevents understanding of cancer inequities across India's diverse population 3. Given that over 55% of gallbladder cancer patients belong to lower socioeconomic classes and treatment dropout correlates significantly with unemployment 7, this data gap directly impedes targeted intervention development.
Follow-up and survival data remain incomplete, with most registries lacking systematic long-term outcome tracking 4. This limits assessment of treatment effectiveness and quality of care across different regions and populations.
Comparison to International Standards
Unlike the U.S. SEER program (covering 28% of population) or NCDB (capturing 70% of new cancer cases) 9, India's registries cover a much smaller population fraction. However, India has adapted unique approaches like home visits for rural case finding that address context-specific challenges 3.
The key distinction is that Indian registries must function within a healthcare system with poor access to cancer diagnosis and treatment, weak death registration, and significant rural-urban disparities—challenges not faced by registries in high-income countries 3.